摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8,12,16,19-Docosatetraenoic acid

中文名称
——
中文别名
——
英文名称
8,12,16,19-Docosatetraenoic acid
英文别名
(8E,12E,16E,19E)-docosa-8,12,16,19-tetraenoic acid
8,12,16,19-Docosatetraenoic acid化学式
CAS
——
化学式
C22H36O2
mdl
——
分子量
332.5
InChiKey
SGTUDMPUJCDZHD-RDQFZKTJSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.9
  • 重原子数:
    24
  • 可旋转键数:
    16
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.59
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

文献信息

  • Cationic cardiolipin analoges and its use thereof
    申请人:Ahmad U. Moghis
    公开号:US20050277611A1
    公开(公告)日:2005-12-15
    The invention provides cationic cardiolipin compounds, and methods for synthesizing and using them in liposomal formulation, gene transfection, etc. In particular, the invention provides liposomes comprising cationic cardiolipin analog, pharmaceutical compositions comprising cationic cardiolipin analogs, and methods of using such liposomes and compositions, in delivering active pharmaceutical agents to treat human and animal diseases and/or in diagnostic assays.
    本发明提供了阳离子心磷脂化合物以及其合成和在脂质体制剂、基因转染等方面的使用方法。特别地,本发明提供了含阳离子心磷脂类似物的脂质体、含阳离子心磷脂类似物的药物组合物以及使用这些脂质体和组合物的方法,用于传递活性药物治疗人类和动物疾病和/或诊断测定。
  • Cardiolipin molecules and methods of synthesis
    申请人:Ahmad U. Moghis
    公开号:US20050266068A1
    公开(公告)日:2005-12-01
    The invention provides new synthetic routes for cardiolipin with different fatty acids and/or alkyl chains with varying chain length and also with or without unsaturation, particularly a short-chain cardiolipin. The methods comprise reacting a 1,2-O-sn-diacyl/1,2-O-sn-dialkyl glycerol or a 2-O-protected glycerol, with a phosphoramidite reagent or a phosphate triester to produce a protected cardiolipin, which is deprotected to prepare the short chain cardiolipin. The reaction schemes can be used to generate new variants of cardiolipin. The cardiolipin prepared by the present methods can be incorporated into liposomes, which can also include active agents such as hydrophobic or hydrophilic drugs. Such liposomes can be used to treat diseases or in diagnostic and/or analytical assays. Liposomes can also include ligands for targeting a particular cell type or specific tissue.
    本发明提供了一种合成不同脂肪酸和/或不同链长烷基的心磷脂的新合成路线,以及具有或不具有不饱和度,特别是一种短链心磷脂。该方法包括将1,2-O-sn-二酰基/1,2-O-sn-二烷基甘油或2-O-保护甘油磷酸酰胺试剂或磷酸三酯反应以产生受保护的心磷脂,然后去保护以制备短链心磷脂。该反应方案可用于生成心磷脂的新变体。通过本方法制备的心磷脂可以被纳入到脂质体中,这些脂质体还可以包括疏性或亲性药物等活性剂。这样的脂质体可以用于治疗疾病或在诊断和/或分析检测中使用。脂质体还可以包括用于靶向特定细胞类型或特定组织的配体
  • Cardiolipin compositions their methods of preparation and use
    申请人:Ahmad U. Moghis
    公开号:US20050181037A1
    公开(公告)日:2005-08-18
    The invention provides new synthetic routes for cardiolipin with different fatty acids and/or alkyl chains with varying chain length and also with or without unsaturation. The reaction schemes can be used to generate new forms of cardiolipin, including cardiolipin variants. The cardiolipin prepared by the present methods can conveniently be incorporated into liposomes and other lipid formulations that can also include active agents such as hydrophobic or hydrophilic drugs. Such formulations can be used to treat diseases or in diagnostic and/or analytical assays. Liposomes also can include ligands, e.g., for targeting them to a cell type or specific tissue.
    本发明提供了一种用于合成不同脂肪酸和/或不同碳链长度以及有或没有不饱和度的磷脂酰肌醇的新合成路线。反应方案可用于生成新形式的磷脂酰肌醇,包括磷脂酰肌醇变异体。通过本方法制备的磷脂酰肌醇可以方便地被纳入脂质体和其他脂质制剂中,这些制剂也可以包括疏性或亲性药物等活性剂。这样的制剂可用于治疗疾病或在诊断和/或分析测定中使用。脂质体还可以包括配体,例如用于将其定向到特定细胞类型或组织的配体
  • CURABLE COMPOSITION AND METHOD FOR IMPROVING RECOVERY PROPERTIES AND CREEP PROPERTIES
    申请人:KANEKA CORPORATION
    公开号:EP1566412A1
    公开(公告)日:2005-08-24
    Disclosed are a curable composition characterized by using a curable composition including an organic polymer (A1) having one or more silicon-containing functional groups capable of cross-linking by forming siloxane bonds in which the one or more silicon-containing functional groups capable of cross-linking by forming siloxane bonds are silicon-containing functional groups each having three or more hydrolyzable groups on one or more silicon atoms thereof; and a method for controlling the recovery properties, durability and creep resistance of the cured article. Herewith, the present invention provides a curable composition capable of giving a cured article excellent in recovery properties, durability and creep resistance, and a method for controlling the recovery properties, durability and creep resistance of the cured article.
    本发明公开了一种可固化组合物,其特征在于使用包括有机聚合物(A1)的可固化组合物,有机聚合物(A1)具有一个或多个含官能团,能够通过形成硅氧烷键而交联,其中能够通过形成硅氧烷键而交联的一个或多个含官能团是在其一个或多个原子上各具有三个或多个可解基团的含官能团;以及控制固化物的恢复性能、耐久性和抗蠕变性的方法。因此,本发明提供了一种可固化组合物,能够使固化物具有优异的恢复性能、耐久性和抗蠕变性,以及一种控制固化物的恢复性能、耐久性和抗蠕变性的方法。
  • CURING COMPOSITION WITH IMPROVED HEAT RESISTANCE
    申请人:KANEKA CORPORATION
    公开号:EP1659155A1
    公开(公告)日:2006-05-24
    The present invention provides a curable composition including: an organic polymer (A) which has on average 1.1 to 50 groups per one molecule thereof each represented by the general formula (1) and has one or more silicon-containing functional groups capable of cross-linking by forming siloxane bonds:         -NR1-C(=O)-     (1) wherein R1 is a hydrogen atom, or a substituted or unsubstituted monovalent organic group; and a metal carboxylate and/or a carboxylic acid (B), the curable composition giving a cured article excellent in curability and also excellent in heat resistance although a non-organotin catalyst is used.
    本发明提供了一种可固化组合物,包括:有机聚合物 (A),其平均每一个分子具有 1.1 至 50 个基团,每个基团由通式 (1) 表示,并具有一个或多个含官能团,能够通过形成硅氧烷键而交联: -NR1-C(=O)- (1) 其中 R1 是氢原子,或取代或未取代的一价有机基团;以及羧酸盐和/或羧酸 (B),尽管使用的是非有机锡催化剂,但这种可固化组合物的固化物具有优异的固化性和耐热性。
查看更多